UiPath (NYSE:PATH – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.06), Zacks reports. UiPath had a return on equity of 7.92% and a net margin of 19.58%.
UiPath Stock Up 0.6%
Shares of PATH traded up $0.10 during trading hours on Thursday, hitting $18.09. The company had a trading volume of 57,811,989 shares, compared to its average volume of 46,094,867. The firm has a market cap of $9.37 billion, a price-to-earnings ratio of 30.15, a PEG ratio of 2.17 and a beta of 1.02. The business has a fifty day moving average of $13.66 and a 200-day moving average of $11.87. UiPath has a 12 month low of $9.20 and a 12 month high of $19.84.
Insider Activity
In related news, CEO Daniel Dines sold 1,402,347 shares of UiPath stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the completion of the sale, the chief executive officer owned 26,491,238 shares of the company’s stock, valued at approximately $425,714,194.66. The trade was a 5.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 22.44% of the company’s stock.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several equities research analysts recently issued reports on PATH shares. Royal Bank Of Canada raised their target price on shares of UiPath from $12.00 to $15.00 and gave the company a “sector perform” rating in a research note on Friday, August 14th. Morgan Stanley lowered their price target on UiPath from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Friday, May 29th. UBS Group upped their price objective on UiPath from $12.00 to $19.00 and gave the company a “neutral” rating in a research note on Monday. Needham & Company LLC raised their price objective on UiPath from $15.00 to $22.00 and gave the company a “buy” rating in a research report on Thursday. Finally, BMO Capital Markets cut their price objective on UiPath from $14.00 to $13.00 and set a “market perform” rating for the company in a research report on Monday, June 1st. Two analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $14.80.
Check Out Our Latest Report on PATH
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Recommended Stories
- Five stocks we like better than UiPath
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
